Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
Harvard Business School
Medtronic
McKinsey
Colorcon

Last Updated: January 26, 2022

DrugPatentWatch Database Preview

Claims for Patent: 6,409,719

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 6,409,719
Title: Light stint implant device for treatment of long term viral infection
Abstract:A light stint implant device adapted to be surgically implanted in a major blood vessel for assisting in the treatment of long term viral infection, alone or in combination with anti-viral drugs, is disclosed. The implant device is programmed for set periods of illumination and set periods of dormancy through a remote power supply and timing device accessible through a sub-dermal implant adapted to be surgically placed in a location under the skin. The device, after being implanted within such blood vessel will eliminate viruses located within the blood through exposure to light given off by the light stint implant device during the periods of illumination.
Inventor(s): Manning; Don A. (Monroeville, AL)
Assignee:
Application Number:09/663,786
Patent Claims:1. A light stint implant device adapted to be surgically implanted in a major artery for assisting in the treatment of long term viral infection, alone or in combination with anti-viral drugs, the invention comprising:

a. a thin, hollow, cylindrical illuminating light stint adapted to be implanted within the major artery having an illuminating means, an inner surface and an outer surface, the outer surface being provided with electrodes;

b. a pair of electronic leads having a first end and a second end, the first end of the electronic leads connected to the electrodes on the outer surface of the illuminating light stint; and

c. a control unit containing a removable access panel, an inner low voltage, long-term power supply connected to the second end of the electronic leads and a programmable timing means connected to the inner low voltage, long-term power supply to periodically activate the inner low voltage, long-term power supply causing such inner low voltage, long-term power supply to activate the illuminating means in the illuminating light stint providing light to the inner surface of the illuminating light stint and blood flowing along the inner surface of the illuminating light stint.

2. The invention as disclosed in claim 1, wherein the illuminating means provides light in the infrared, visible and ultraviolet spectrum.

3. The invention, as disclosed in claim 1, wherein the invention is utilized in conjunction with leukine and sargramostim for the treatment of AIDS.

4. The invention as disclosed in claim 1, further comprising the control unit having a remote transmission receiver for remotely reprogramming the programmable timing means, avoiding the need to access such programmable timing means through the removable access panel.

Details for Patent 6,409,719

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Partner Therapeutics, Inc. LEUKINE sargramostim For Injection 103362 1991-03-05 ⤷  Sign up for a Free Trial 2039-02-26
Partner Therapeutics, Inc. LEUKINE sargramostim Injection 103362 1991-03-05 ⤷  Sign up for a Free Trial 2039-02-26
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Dow
Mallinckrodt
McKesson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.